New Key Statistics Module, Z-Score and F-Score
SZSE:002788 Key Ratios
Market Cap ¥ M | 3,407.29 |
Enterprise Value ¥ M | 7,990.27 |
P/E(ttm) | 9.52 |
PE Ratio without NRI | 9.52 |
Forward PE Ratio | -- |
Price/Book | 1.11 |
Price/Sales | 0.16 |
Price/Free Cash Flow | 6.71 |
Price/Owner Earnings | 52.52 |
Payout Ratio % | 0.33 |
Revenue (TTM) ¥ M | 20,483.00 |
EPS (TTM) ¥ | 0.92 |
Beneish M-Score | -2.65 |
10-y EBITDA Growth Rate % | 11.50 |
5-y EBITDA Growth Rate % | 11.50 |
y-y EBITDA Growth Rate % | 5.50 |
EV-to-EBIT | 11.33 |
EV-to-EBITDA | 11.33 |
PEG | 0.83 |
Shares Outstanding M | 388.52 |
Net Margin (%) | 1.75 |
Operating Margin % | 3.57 |
Pre-tax Margin (%) | 2.35 |
Quick Ratio | 0.83 |
Current Ratio | 1.15 |
ROA % (ttm) | 3.01 |
ROE % (ttm) | 11.96 |
ROIC % (ttm) | 7.18 |
Dividend Yield % | 3.44 |
Altman Z-Score | 2.39 |
SZSE:002788 Number of Guru Trades
SZSE:002788 Volume of Guru Trades
Gurus Latest Trades with SZSE:002788
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002788 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Luyan Pharma Co Ltd Insider Transactions
No Available Data